Ledger.Open graph →
SEC Form D · filed May 20, 2016

NovaBay Pharmaceuticals, Inc

Offering
$11.8M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
EMERYVILLE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

T. A. Mcpherson · Emeryville, CADirectorThomas J. Paulson · Emeryville, CAExecPaul E. Freiman · Emeryville, CADirectorJustin M. Hall · Emeryville, CAExecMark M. Sieczkarek · Emeryville, CAExec · DirectorGail J. Maderis · Emeryville, CADirectorXinzhou (Paul) E. Li · Emeryville, CADirectorXiaoyan (Henry) A. Liu · Emeryville, CADirectorMijia (Bob) M. Wu · Emeryville, CADirectorTodd A. Zavodnick · Emeryville, CADirectorTimothy Baldwin · PHOENIX, AZDirectorStephen Campbell · PHOENIX, AZDirectorThomas J. Paulson · Emeryville, CAExecIan F. Kennedy · NEWPORT BEACH, CAExec · DirectorPeter R. Mcdermott · Denver, COExecSteven S. Siegel · Denver, CODirectorHal R. Shaw · Denver, CODirectorPeter F. Palmedo · Sun Valley, IDExec · DirectorShawn K. O'Neill · Menlo Park, CAExecVivek Jayan · Fremont, CADirectorJayan Ramankutty · Fremont, CADirectorCarl J. Schramm · New York, NYExecParthasarathy Krishnan · New York, NYDirectorGavriel J. Ralbag · New York, NYDirectorXiaoyan (Henry) A. Liu · Emeryville, CADirectorMijia (Bob) M. Wu · Emeryville, CADirectorTodd A. Zavodnick · Emeryville, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗